DR
Dr. Martens plc
DRMTY · OTC
$1.95 +5.98% (+$0.11)
1M -18.58%
Market Cap £698.0M
P/E Ratio 28.86x
Div. Yield 3.51%
ROE 6.95%
Bulios Fair Price
$1.89
3.1% downside
Current Price
$1.95
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DRMTY is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
86 /100
Cheap EV/EBITDA 6.17x
P/S 0.90x
P/B 1.93x
Growth
26 /100
Declining Rev. growth 8.06%
FCF growth 65.87%
Book val. growth 3.65%
Profitability
64 /100
Moderate Net margin 3.11%
Op. margin 9.98%
FCF margin 15.20%
Quality
41 /100
Average ROE 6.95%
ROA 2.76%
Asset turnover 0.89x
Debt
63 /100
Moderate Current ratio 2.61x
Int. coverage 2.75x
Net debt/EBITDA 1.43x
Stability
49 /100
Moderate Rev. volatility 5.85%
EPS volatility 268.62%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DRMTY
Online
Sector
Consumer Cyclical
Industry
Apparel - Footwear & Accessories
CEO
Ije Nwokorie
Employees
2,377
Headquarters
London